Sg3 Management, LLC Curis Inc Call Options Transaction History

Sg3 Management, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$2.31 - $5.13 $364,980 - $810,540	-158,000 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$4.45 - $8.09 $703,100 - $1.28 Million	158,000 New	158,000 $752,000
Q3 2021 Nov 15, 2021	SELL	$6.94 - $8.85 $231,796 - $295,590	-33,400 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$7.45 - $16.27 $15,645 - $34,167	-2,100 Reduced 5.92%	33,400 $270,000
Q1 2021 May 17, 2021	BUY	$8.78 - $12.8 $311,690 - $454,400	35,500 New	35,500 $402,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.